In a study published in Advanced Functional Materials, a research team from the Shanghai Institute of Materia Medica (SIMM) ...

Taking race into account when developing tools to predict a patient's risk of colorectal cancer leads to more accurate ...

The research team was able to establish that tumor cells dying off ... Identification of the Cells Responsible for Colon Cancer Relapse Nov. 9, 2022 — Researchers report the discovery of the ...

Innovent Biologics has made the case that its checkpoint inhibitor-cytokine fusion protein has a future in colorectal cancer.

As it works to diversify its methods for catching early cases of colorectal cancer, Exact Sciences has put forward clinical ...

By Roni Caryn Rabin Adults under age 50 have been developing breast cancer and colorectal ... squamous cell carcinoma and certain types of head, neck, breast, colorectal, liver and stomach cancers ...

Improvements in endoscopy techniques and imaging will certainly allow for better detection and minimal-invasive treatment of early colorectal neoplasia and precancers. However, the fundamental aim ...

Although the role of innate immune sensing pathways is well-studied in the pathogenesis of malignancies, whether they ...

Exact Sciences, which has for years sold a stool-based colon cancer test, on Monday announced that a blood-based test it’s developing showed promise in accurately detecting the disease.

Kulkarni's colorectal cancer was Stage 4. “That’s when the ground fell out from beneath me, basically. And I will never forget that feeling. But I will tell you that was the one day that I ...

Exact Sciences has a multipronged approach to cancer testing. Current products are Cologuard, its flagship stool-based screening test for colorectal ... to advanced adenomas and Stage I tumors.